Savara (SVRA) Interest Expenses (2011 - 2018)

Savara (SVRA) reported Interest Expenses of $113000.0 for Q2 2018, down 78.1% year-over-year from $516000.0 in Q2 2017, and up 8.65% quarter-over-quarter from $104000.0 in Q1 2018.

Savara (SVRA) Interest Expenses (2011 - 2018) Analysis & Trends

Savara (SVRA) has 6 years of Interest Expenses data on file, last reported at $113000.0 in Q2 2018.

  • Interest Expenses for Q2 2018 came in at $113000.0, down 78.1% year-over-year; the trailing twelve-month figure through Mar 2019 was $113000.0 (down 88.92% YoY), and the FY2017 annual result was $1.2 million, up 156.86% from the prior year.
  • Interest Expenses improved to $113000.0 in Q2 2018 per SVRA's latest filing, from $104000.0 in the prior quarter.
  • Over five years, Interest Expenses peaked at $2.5 million in Q4 2015 and troughed at $1000.0 in Q2 2015.
  • A 4-year average of $378769.2 and a median of $190000.0 in 2016 frame the typical range for Interest Expenses.
  • The sharpest annual moves came in 2016 and 2017: Interest Expenses plunged 90.13% in 2016, then surged 7271.43% in 2017.
  • A 4-year view of Interest Expenses shows it stood at $2.5 million in 2015, then sank by 90.13% to $245000.0 in 2016, then plunged by 49.8% to $123000.0 in 2017, then fell by 8.13% to $113000.0 in 2018.
  • Business Quant data shows SVRA's Interest Expenses at $113000.0 in Q2 2018, $104000.0 in Q1 2018, and $123000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -5.50 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -332,000.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 61,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -2,753.00
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -5.58 Mn
10 Savara 1.39 Bn 1.39 Bn - -

Historic Data

Download Data
DateValue
Jun 30, 2018 113,000.00
Jun 30, 2018 113,000.00
Mar 31, 2018 104,000.00
Mar 31, 2018 104,000.00
Dec 31, 2017 123,000.00
Dec 31, 2017 123,000.00
Sep 30, 2017 277,000.00
Sep 30, 2017 277,000.00
Jun 30, 2017 516,000.00
Jun 30, 2017 516,000.00
Mar 31, 2017 245,000.00
Mar 31, 2017 245,000.00
Dec 31, 2016 245,000.00
Dec 31, 2016 245,000.00
Sep 30, 2016 190,000.00
Sep 30, 2016 190,000.00
Jun 30, 2016 7,000.00
Jun 30, 2016 7,000.00
Mar 31, 2016 519,000.00
Mar 31, 2016 519,000.00